HK1187898A1 - Pyrazole compound having therapeutic effect on multiple myeloma - Google Patents
Pyrazole compound having therapeutic effect on multiple myelomaInfo
- Publication number
- HK1187898A1 HK1187898A1 HK14100322.3A HK14100322A HK1187898A1 HK 1187898 A1 HK1187898 A1 HK 1187898A1 HK 14100322 A HK14100322 A HK 14100322A HK 1187898 A1 HK1187898 A1 HK 1187898A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- therapeutic effect
- multiple myeloma
- pyrazole compound
- pyrazole
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010268758 | 2010-12-01 | ||
| JP2011217818 | 2011-09-30 | ||
| PCT/JP2011/077829 WO2012074067A1 (ja) | 2010-12-01 | 2011-12-01 | 多発性骨髄腫の治療効果を有するピラゾール化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1187898A1 true HK1187898A1 (en) | 2014-04-17 |
Family
ID=46171992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14100322.3A HK1187898A1 (en) | 2010-12-01 | 2014-01-10 | Pyrazole compound having therapeutic effect on multiple myeloma |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8658686B2 (ja) |
| EP (1) | EP2647629B1 (ja) |
| JP (1) | JP5857972B2 (ja) |
| KR (1) | KR20130121857A (ja) |
| CN (1) | CN103237793B (ja) |
| BR (1) | BR112013015774A2 (ja) |
| CA (1) | CA2819215C (ja) |
| DK (1) | DK2647629T3 (ja) |
| ES (1) | ES2541289T3 (ja) |
| HK (1) | HK1187898A1 (ja) |
| IL (1) | IL226663A (ja) |
| MY (1) | MY165634A (ja) |
| NZ (1) | NZ611169A (ja) |
| PL (1) | PL2647629T3 (ja) |
| RU (1) | RU2583430C2 (ja) |
| SG (1) | SG190957A1 (ja) |
| WO (1) | WO2012074067A1 (ja) |
| ZA (1) | ZA201303877B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
| CN105102448B (zh) | 2013-02-28 | 2018-03-06 | 百时美施贵宝公司 | 作为rock1和rock2抑制剂的苯基吡唑衍生物 |
| AU2015217450A1 (en) | 2014-02-14 | 2016-08-11 | Inception 2, Inc. | Pyrazolone compounds and uses thereof |
| WO2018134127A1 (en) | 2017-01-23 | 2018-07-26 | Basf Se | Fungicidal pyridine compounds |
| US11512067B2 (en) | 2017-09-14 | 2022-11-29 | Daiichi Sankyo Company, Limited | Compound having cyclic structure |
| RU2020132289A (ru) * | 2018-03-02 | 2022-04-04 | Юниверсите Де Лозанн | Производные пиразола в качестве ингибиторов сигнального пути wnt |
| KR102459196B1 (ko) * | 2022-04-08 | 2022-10-27 | 케이블루바이오 주식회사 | 신규한 크로마논 화합물을 유효성분으로 포함하는 다발성골수종의 예방 또는 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2319279A1 (de) * | 1973-04-17 | 1974-11-07 | Bayer Ag | Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| JPS6277371A (ja) | 1985-09-30 | 1987-04-09 | Neos Co Ltd | 含フツ素ピラゾ−ル誘導体 |
| RU2294931C2 (ru) | 2000-05-11 | 2007-03-10 | Консехо Супериор Инвестигасионес Сьентификас | Гетероциклические ингибиторы гликоген-синтазы киназы gsk-3 |
| DE60135676D1 (de) | 2000-12-05 | 2008-10-16 | Vertex Pharma | Inhibitoren von c-jun n-terminalen kinasen (jnk) und anderen proteinkinasen |
| CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| CN101218207A (zh) | 2005-07-06 | 2008-07-09 | 默克弗罗斯特加拿大有限公司 | 组织蛋白酶半胱氨酸蛋白酶抑制剂 |
| WO2007105058A2 (en) * | 2006-03-16 | 2007-09-20 | Pfizer Products Inc. | Pyrazole compounds |
| CN101679297B (zh) | 2006-12-08 | 2012-01-11 | 埃克塞利希斯股份有限公司 | Lxr和fxr调节剂 |
| DK2288610T3 (en) * | 2008-03-11 | 2016-11-28 | Incyte Holdings Corp | Azetidinesulfonic AND CYCLOBUTANDERIVATER AS JAK INHIBITORS |
| JP5775070B2 (ja) * | 2009-05-22 | 2015-09-09 | インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ | ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体 |
-
2011
- 2011-12-01 JP JP2012546943A patent/JP5857972B2/ja active Active
- 2011-12-01 BR BR112013015774-7A patent/BR112013015774A2/ja active Search and Examination
- 2011-12-01 DK DK11845115.2T patent/DK2647629T3/en active
- 2011-12-01 CA CA2819215A patent/CA2819215C/en not_active Expired - Fee Related
- 2011-12-01 KR KR1020137013962A patent/KR20130121857A/ko active IP Right Grant
- 2011-12-01 ES ES11845115.2T patent/ES2541289T3/es active Active
- 2011-12-01 PL PL11845115T patent/PL2647629T3/pl unknown
- 2011-12-01 US US13/991,024 patent/US8658686B2/en active Active
- 2011-12-01 NZ NZ611169A patent/NZ611169A/en not_active IP Right Cessation
- 2011-12-01 EP EP11845115.2A patent/EP2647629B1/en active Active
- 2011-12-01 CN CN201180057443.9A patent/CN103237793B/zh active Active
- 2011-12-01 SG SG2013042395A patent/SG190957A1/en unknown
- 2011-12-01 WO PCT/JP2011/077829 patent/WO2012074067A1/ja active Application Filing
- 2011-12-01 MY MYPI2013001987A patent/MY165634A/en unknown
- 2011-12-01 RU RU2013129861/04A patent/RU2583430C2/ru not_active IP Right Cessation
-
2013
- 2013-05-28 ZA ZA2013/03877A patent/ZA201303877B/en unknown
- 2013-05-30 IL IL226663A patent/IL226663A/en active IP Right Grant
-
2014
- 2014-01-10 HK HK14100322.3A patent/HK1187898A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK2647629T3 (en) | 2015-07-27 |
| EP2647629B1 (en) | 2015-06-17 |
| US20130253204A1 (en) | 2013-09-26 |
| JPWO2012074067A1 (ja) | 2014-05-19 |
| AU2011337594A1 (en) | 2013-06-20 |
| MY165634A (en) | 2018-04-18 |
| EP2647629A4 (en) | 2014-04-23 |
| CN103237793B (zh) | 2015-06-10 |
| ES2541289T3 (es) | 2015-07-17 |
| NZ611169A (en) | 2014-05-30 |
| PL2647629T3 (pl) | 2015-12-31 |
| WO2012074067A1 (ja) | 2012-06-07 |
| RU2013129861A (ru) | 2015-01-10 |
| CA2819215A1 (en) | 2012-06-07 |
| IL226663A (en) | 2016-11-30 |
| CA2819215C (en) | 2018-05-01 |
| KR20130121857A (ko) | 2013-11-06 |
| AU2011337594B2 (en) | 2016-03-10 |
| CN103237793A (zh) | 2013-08-07 |
| ZA201303877B (en) | 2014-07-30 |
| EP2647629A1 (en) | 2013-10-09 |
| RU2583430C2 (ru) | 2016-05-10 |
| US8658686B2 (en) | 2014-02-25 |
| SG190957A1 (en) | 2013-07-31 |
| JP5857972B2 (ja) | 2016-02-10 |
| BR112013015774A2 (ja) | 2018-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201308600B (en) | Novel pesticidal pyrazole compounds | |
| ZA201401553B (en) | Cyclopropaneamine compound | |
| ZA201304282B (en) | Pyrazole derivative | |
| WO2012088388A9 (en) | Treating multiple myeloma | |
| PL2611297T3 (pl) | Grzybobójcze pirazole | |
| ZA201308918B (en) | Multiple myeloma treatment | |
| HK1187898A1 (en) | Pyrazole compound having therapeutic effect on multiple myeloma | |
| EP2708540A4 (en) | PYRIMIDO-DIAZEPINONE COMPOUND | |
| HK1188597A1 (en) | Continuous arycyclic compound | |
| EP2635274A4 (en) | CELECOXIB DERIVATIVES AGAINST STAPHYLOKOKEN | |
| GB201002911D0 (en) | Compound | |
| GB201017315D0 (en) | Compound | |
| GB201016761D0 (en) | Herbicidal compounds | |
| HK1180971A1 (zh) | 吡唑化合物 | |
| ZA201303800B (en) | Pyrazole compounds | |
| AU2011337594B9 (en) | Pyrazole compound having therapeutic effect on multiple myeloma | |
| GB201007209D0 (en) | Compound | |
| GB201104669D0 (en) | Compound | |
| GB201000771D0 (en) | Compound for therapy | |
| GB201005435D0 (en) | Sp2 | |
| GB201021228D0 (en) | Compound | |
| GB201015798D0 (en) | Compound | |
| GB201008820D0 (en) | Compound | |
| GB201005980D0 (en) | Compound | |
| GB201121538D0 (en) | Compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20191130 |